Stocktoria

Silo Pharma, Inc. SILO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-01-05

Silo Pharma, Inc. statistics & valuation

Market cap$6.8M
P / S94.6×
P / B1.1×
Net margin-5863.5%
Return on equity-67.0%
Return on capital-61.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-2497.70% -7422.50% -5420.90% -5132.60% -6092.60% -5863.50% 2013201720182019202020212022202320242025
Gross margin (%)
32.50% -330.40% 91.90% 91.90% 91.90% 38.60% 2013201720182019202020212022202320242025
Operating margin (%)
-2293.40% -5380.20% -5031.30% -5347.40% -6526.40% -5937.00% 2013201720182019202020212022202320242025
Return on equity (%)
29.60% -237.90% -237.20% 43.10% -37.80% -59.90% -87.30% -67.00% 2013201720182019202020212022202320242025
Shares outstanding
40.6M 52.1M 49.1M 23.6M 85.1M 2.0M 3.2M 3.1M 4.5M 13.3M 2013201720182019202020212022202320242025
Net debt ($)
2013201720182019202020212022202320242025
Share buybacks ($)
2013201720182019202020212022202320242025
Return on assets (%)
21.70% -113.30% -205.20% -212.90% 37.20% -33.60% -47.80% -59.30% -55.60% 2013201720182019202020212022202320242025
Free cash flow margin (%)
2013201720182019202020212022202320242025
Debt / equity (×)
2013201720182019202020212022202320242025
EPS ($)
$0.01 -$0.02 -$0.05 $0.04 -$1.20 -$1.19 -$0.50 2013201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2013
Gross margin38.6%91.9%91.9%91.9%—-330.4%32.5%———
Operating margin-5937.0%-6526.4%-5347.4%-5031.3%—-5380.2%-2293.4%———
Net margin-5863.5%-6092.6%-5132.6%-5420.9%—-7422.5%-2497.7%———
Return on assets-55.6%-59.3%-47.8%-33.6%37.2%-212.9%-205.2%-113.3%21.7%—
Return on equity-67.0%-87.3%-59.9%-37.8%43.1%-237.2%4426.4%-237.9%29.6%—
Current ratio11.364.299.9026.5221.2310.074.2313.0542.81—

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.